Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer

被引:0
作者
K D Sørensen
M O Abildgaard
C Haldrup
B P Ulhøi
H Kristensen
S Strand
C Parker
S Høyer
M Borre
T F Ørntoft
机构
[1] Aarhus University Hospital,Department of Molecular Medicine
[2] Aarhus University Hospital,Department of Urology
[3] Brendstrupgaardsvej 100,undefined
[4] DK-8200 Aarhus N,undefined
[5] Institute of Pathology,undefined
[6] Aarhus University Hospital,undefined
[7] Nørrebrogade,undefined
[8] DK-8000,undefined
[9] Aarhus C,undefined
[10] Academic Unit of Radiotherapy and Oncology,undefined
[11] Institute of Cancer Research and Royal Marsden NHS Foundation Trust,undefined
来源
British Journal of Cancer | 2013年 / 108卷
关键词
prostate cancer; prognosis; biomarker; tissue microarray; DNA methylation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:420 / 428
页数:8
相关论文
共 291 条
[1]  
Abildgaard MO(2012)Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis Int J Cancer 130 885-895
[2]  
Borre M(1997)Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue Prostate 33 225-232
[3]  
Mortensen MM(1997)The natural history of prostate carcinoma based on a Danish population treated with no intent to cure Cancer 80 917-928
[4]  
Ulhøi BP(2000)Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting Clin Cancer Res 6 1882-1890
[5]  
Tørring N(1998)Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting Br J Cancer 78 940-944
[6]  
Wild P(2010)Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? Am J Pathol 177 2216-2224
[7]  
Kristensen H(2006)Ectopeptidases in tumour biology: a review Histol Histopathol 21 1339-1353
[8]  
Mansilla F(2007)Differential expression of CD10 in prostate cancer and its clinical implication BMC Urol 7 3-1242
[9]  
Ottosen PD(2005)The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 1228-4715
[10]  
Dyrskjøt L(2009)Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer Cancer Res 69 4708-90